V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003867 | 310001622 | 0 | 48.1 | Palliative (P) | 2015-08-05 | 2015-08-08 | Bexarotene | N | N | 310018779 | CAPECITABINE + CISPLATIN |
| 310003868 | 310001622 | 1.7 | 81.2 | Adjuvant (A) | 2013-08-13 | 2013-08-19 | NB HRNBL-1 COJEC Ind COURSE A | 02 | N | 310018779 | CAPECITABINE |
| 310003869 | 310009117 | 1.67 | 60.6 | Neo-adjuvant (N) | null | 2015-12-25 | ECX | 02 | N | 310018784 | ECX |
| 310003870 | 310009117 | 1.55 | 65.7 | Palliative (P) | 2016-03-29 | 2016-03-29 | Hydroxycarbamide | 02 | N | 310018784 | ICON TRIAL |
| 310003871 | 310009117 | 1.72 | 91.5 | Palliative (P) | 2016-01-24 | 2016-02-08 | EOX | N | N | 310018784 | CAPECITABINE + OXALIPLATIN |
| 310003872 | 310001623 | null | 53.4 | Palliative (P) | 2015-10-19 | 2015-10-25 | Cisplatin + Docetaxel +Fluorouracil | N | null | 310018789 | MITOMYCIN INTRAVESICULAR |
| 310003873 | 310001623 | 1.59 | 59.6 | Palliative (P) | 2018-01-10 | 2018-01-17 | BCG Intravesical | null | null | 310018789 | IMATINIB |
| 310003874 | 310001624 | 1.7 | 0 | Palliative (P) | 2015-05-23 | 2015-06-28 | ICON8 TRIAL | N | N | 310018793 | CISPLATIN + FLUOROURACIL |
| 310003875 | 310006717 | null | null | Palliative (P) | 2014-03-27 | 2014-04-07 | CAPECITABINE + OXALIPLATIN | N | N | 310018796 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310003876 | 310006717 | 1.59 | 69.2 | Palliative (P) | 2014-12-01 | 2014-12-14 | EOX | N | N | 310018796 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310003877 | 310006717 | 1.58 | null | Palliative (P) | 2014-10-12 | 2014-10-13 | ECX | null | null | 310018796 | ECX |
| 310003878 | 310001625 | 1.64 | 59.6 | Adjuvant (A) | 2013-04-13 | 2013-04-29 | GEMCITABINE | N | N | 310018802 | GEMCITABINE |
| 310003879 | 310001626 | null | 83.9 | Curative (C) | 2015-02-12 | 2015-02-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310018804 | ICON TRIAL |
| 310003880 | 310001626 | 1.76 | 79 | Palliative (P) | 2016-12-08 | 2016-12-24 | ECX | N | Y | 310018804 | ECX |
| 310003881 | 310009119 | 0 | 97 | Palliative (P) | 2015-06-25 | 2015-06-25 | Bexarotene | N | N | 310018809 | ICON TRIAL |
| 310003882 | 310009119 | null | 76.4 | Palliative (P) | 2013-03-16 | 2013-03-23 | Vemurafenib | N | N | 310018809 | CAPECITABINE + CISPLATIN |
| 310003883 | 310009119 | 1.84 | 72 | Palliative (P) | 2015-05-28 | 2015-06-18 | Cisplatin + Etoposide (3 day) | 2 | N | 310018809 | OXALIPLATIN + MDG |
| 310003884 | 310011451 | 1.6 | null | Palliative (P) | 2016-09-17 | 2016-09-24 | Dacarbazine | N | N | 310018813 | ICON TRIAL |
| 310003885 | 310001627 | 1.6 | 78.95 | Palliative (P) | 2016-09-10 | 2016-09-12 | Bexarotene | 02 | N | 310018814 | LIPOSOMAL DOXORUBICIN |
| 310003886 | 310001628 | null | 85.8 | Palliative (P) | 2013-10-24 | 2013-10-31 | ECX | 02 | N | 310018817 | ECX |
| 310003887 | 310001629 | 1.65 | 78.4 | Palliative (P) | 2016-09-06 | 2016-09-12 | BEVACIZUMAB + CARBO + PACLITAXEL | null | null | 310018818 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310003888 | 310001630 | null | 71.4 | Palliative (P) | 2017-09-22 | 2017-10-05 | ECX | 2 | null | 310018820 | ECX |
| 310003889 | 310001631 | 1.79 | 75.3 | Not known (9) | 2017-09-04 | 2017-09-27 | Vemurafenib | 2 | N | 310018821 | CISPLATIN + FLUOROURACIL |
| 310003890 | 310001632 | 1.77 | 79 | Palliative (P) | 2014-11-12 | 2014-11-27 | Dacarbazine | 2 | N | 310018823 | CAPECITABINE + OXALIPLATIN |
| 310003891 | 310001633 | 1.84 | 80.7 | Palliative (P) | 2017-10-21 | 2017-10-24 | IPILIMUMAB + NIVOLUMAB | N | N | 310018824 | IPILIMUMAB + NIVOLUMAB |
| 310003892 | 310006719 | 0 | 74 | Palliative (P) | null | 2016-07-03 | null | N | N | 310018827 | NOT MATCHED |
| 310003893 | 310006719 | 1.68 | 129 | Palliative (P) | 2013-03-28 | 2013-04-03 | CAPECITABINE + OXALIPLATIN | N | N | 310018827 | CAPECITABINE |
| 310003894 | 310006719 | 1.77 | null | Curative (C) | 2016-10-02 | 2016-10-27 | ICON8 TRIAL | N | N | 310018827 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310003895 | 310011062 | 1.73 | 66.9 | Curative (C) | 2015-02-13 | 2015-02-17 | GEMCITABINE | N | N | 310018833 | GEMCITABINE |
| 310003896 | 310011062 | 1.19 | 49.8 | Palliative (P) | 2017-01-04 | 2017-01-04 | Hydroxycarbamide | 02 | N | 310018833 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310003897 | 310001634 | 0 | 75 | Curative (C) | 2013-11-08 | 2014-07-30 | null | 02 | Y | 310018842 | NOT MATCHED |
| 310003898 | 310001634 | null | 49.8 | Palliative (P) | 2015-06-30 | 2015-06-30 | BCG Intravesical | null | Y | 310018842 | PACLITAXEL |
| 310003899 | 310001634 | 0 | 70 | Palliative (P) | 2016-08-05 | 2016-08-05 | ECX | 02 | N | 310018842 | ECX |
| 310003900 | 310001635 | null | 82.1 | Palliative (P) | 2017-05-15 | 2017-05-16 | Liposomal Doxorubicin 50mg/m2 | N | null | 310018846 | CAPECITABINE + CISPLATIN |
| 310003901 | 310001636 | null | 82.4 | Palliative (P) | 2016-09-02 | 2016-09-16 | Capecitabine + Oxaliplatin 21day | 02 | N | 310018847 | EOX |
| 310003902 | 310001637 | 1.75 | 102 | Disease modification (D) | 2018-06-07 | 2018-06-09 | Hydroxycarbamide | N | N | 310018848 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310003903 | 310001638 | 1.55 | 62.7 | Curative (C) | 2015-12-13 | 2015-12-13 | CHOEP | 02 | N | 310018850 | BCG |
| 310003904 | 310001639 | 1.56 | 91 | Palliative (P) | 2019-01-03 | 2019-01-17 | IPILIMUMAB + NIVOLUMAB | null | null | 310018851 | IPILIMUMAB + NIVOLUMAB |
| 310003905 | 310001639 | 0 | 57.7 | null | 2014-07-03 | 2014-07-10 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018851 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310003906 | 310001639 | null | 98 | Palliative (P) | 2015-03-06 | 2015-03-15 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 310018851 | OXALIPLATIN + MDG |
| 310003907 | 310001639 | 1.78 | 65 | Palliative (P) | 2017-09-02 | 2017-09-03 | Mitomycin Intravesical | 02 | N | 310018851 | OXALIPLATIN + MDG |
| 310003908 | 310001640 | 1.8 | 132.1 | Palliative (P) | 2017-12-30 | 2017-12-30 | ECX | 2 | N | 310018857 | ECX |
| 310003909 | 310001640 | 1.84 | 0 | Palliative (P) | 2016-01-30 | 2016-02-04 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018857 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310003910 | 310001641 | 1.8 | 104.8 | Curative (C) | 2014-05-17 | 2014-05-17 | CHOEP | N | N | 310018859 | PACLITAXEL |
| 310003911 | 310001642 | 1.8 | 79.2 | Not known (9) | null | 2016-06-26 | EOX | 2 | N | 310018860 | EOX |
| 310003912 | 310001643 | 1.5 | 72 | Palliative (P) | 2016-02-24 | 2016-03-18 | Cisplatin +Fluorouracil (3 wk) | N | N | 310018863 | OXALIPLATIN + MDG |
| 310003913 | 310001644 | 1.74 | 55.4 | Palliative (P) | 2015-06-22 | 2015-07-16 | Capecitabine + Cisplatin | N | N | 310018864 | IMATINIB |
| 310003914 | 310001645 | 1.8 | 43 | Disease modification (D) | 2014-08-07 | 2014-08-19 | EOX | null | null | 310018866 | CISPLATIN + FLUOROURACIL |
| 310003915 | 310001646 | null | null | null | null | 2017-08-25 | Bexarotene | Y | N | 310018871 | IMATINIB |
| 310003916 | 310001646 | 1.76 | 48.4 | Curative (C) | 2016-08-15 | 2016-08-15 | EOX | N | N | 310018871 | DACARBAZINE |